Background: Drugs taken during pregnancy can influence a child’s development, such as neurodevelopmental outcomes, that may only manifest years after birth. This temporal disconnect of short-term prenatal exposure with delayed outcomes presents challenges in quantifying exposure-response (ER) relationships. To address this, we developed a population pharmacokinetic-pharmacodynamic (PK/PD) modeling framework that characterizes in utero drug exposure and delayed […]
